Literature DB >> 15490111

Renal disease in rats with type 2 diabetes is associated with decreased renal nitric oxide production.

A Erdely1, G Freshour, D A Maddox, J L Olson, L Samsell, C Baylis.   

Abstract

AIMS/HYPOTHESIS: In several other models of chronic renal disease, decreases in renal nitric oxide activity and nitric oxide synthase (NOS) protein abundance have been demonstrated. Here, we studied diabetic obese Zucker (ZDF Gmi fa/fa) rats that develop severe hyperglycaemia and renal disease, together with their lean control animals, to determine if renal nitric oxide deficiency also occurs in this model.
METHODS: Obese Zucker rats aged 10 to 12 weeks were maintained on Purina 5008 diet until 4, 8, or 11 months of age and compared with similarly maintained, 4- and 11-month-old lean Zucker rats. NOS activity and abundance of endothelial NOS (eNOS) and neuronal NOS (nNOS) were measured on homogenates of kidney cortex. Blood was analysed for glucose, lipids, creatinine, and blood urea nitrogen and kidney tissue was obtained for histology.
RESULTS: Obese rats exhibited severe hyperglycaemia from 4 months of age and developed increasing hyperlipidaemia, proteinuria, and decreasing renal function with age compared to lean counterparts. At 4 months cortical NOS activity and nNOS abundance were lower in obese rats than in lean ones. At 11 months NOS activity remained depressed and nNOS abundance had declined further in obese rats. Glomerulosclerosis in the obese rats was mild at 4 months, becoming severe by 11 months. Lean rats had only mild age-dependent increases in glomerular injury. CONCLUSIONS/
INTERPRETATION: The chronic renal disease that occurs in hyperglycaemic, obese Zucker rats is associated with decreased renal cortical nitric oxide production and increasing renal injury, although the changes do not resemble those of diabetic nephropathy in man.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15490111      PMCID: PMC2765212          DOI: 10.1007/s00125-004-1509-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  11 in total

1.  Protection against puromycin aminonucleoside-induced chronic renal disease in the Wistar-Furth rat.

Authors:  Aaron Erdely; Gary Freshour; Cheryl Smith; Kevin Engels; Jean L Olson; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2004-03-23

2.  White adipose tissue nitric oxide synthase: a potential source for NO production.

Authors:  C Ribiere; A M Jaubert; N Gaudiot; D Sabourault; M L Marcus; J L Boucher; D Denis-Henriot; Y Giudicelli
Journal:  Biochem Biophys Res Commun       Date:  1996-05-24       Impact factor: 3.575

Review 3.  Measurement of nitrite and nitrate levels in plasma and urine--what does this measure tell us about the activity of the endogenous nitric oxide system?

Authors:  C Baylis; P Vallance
Journal:  Curr Opin Nephrol Hypertens       Date:  1998-01       Impact factor: 2.894

4.  Renal and systemic nitric oxide synthesis in rats with renal mass reduction.

Authors:  S Aiello; M Noris; M Todeschini; S Zappella; C Foglieni; A Benigni; D Corna; C Zoja; D Cavallotti; G Remuzzi
Journal:  Kidney Int       Date:  1997-07       Impact factor: 10.612

Review 5.  Rodent models of nephropathy associated with type II diabetes.

Authors:  U Janssen; A O Phillips; J Floege
Journal:  J Nephrol       Date:  1999 May-Jun       Impact factor: 3.902

6.  Total nitric oxide production is low in patients with chronic renal disease.

Authors:  R J Schmidt; C Baylis
Journal:  Kidney Int       Date:  2000-09       Impact factor: 10.612

7.  Protection of wistar furth rats from chronic renal disease is associated with maintained renal nitric oxide synthase.

Authors:  Aaron Erdely; Laszlo Wagner; Veronica Muller; Attila Szabo; Chris Baylis
Journal:  J Am Soc Nephrol       Date:  2003-10       Impact factor: 10.121

Review 8.  Paradoxes of nitric oxide in the diabetic kidney.

Authors:  Radko Komers; Sharon Anderson
Journal:  Am J Physiol Renal Physiol       Date:  2003-06

9.  Peroxisome proliferator-activated receptor [gamma] agonist provides superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity.

Authors:  Chris Baylis; Elke-Astrid Atzpodien; Gary Freshour; Kevin Engels
Journal:  J Pharmacol Exp Ther       Date:  2003-10-14       Impact factor: 4.030

10.  Prevention of obesity-linked renal disease: age-dependent effects of dietary food restriction.

Authors:  David A Maddox; Fred K Alavi; Robert N Santella; Edward T Zawada
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

View more
  17 in total

1.  Glomerular-specific protein kinase C-β-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity.

Authors:  Akira Mima; Yuzuru Ohshiro; Munehiro Kitada; Motonobu Matsumoto; Pedro Geraldes; Chenzhong Li; Qian Li; Gregory S White; Christopher Cahill; Christian Rask-Madsen; George L King
Journal:  Kidney Int       Date:  2011-01-12       Impact factor: 10.612

2.  Endothelial cell-specific overexpression of endothelial nitric oxide synthase in Ins2Akita mice exacerbates diabetic nephropathy.

Authors:  Mohan Natarajan; Samy L Habib; Robert L Reddick; Caroline R Delma; Krishnan Manickam; Thomas J Prihoda; Sherry L Werner; Sumathy Mohan
Journal:  J Diabetes Complications       Date:  2018-10-13       Impact factor: 2.852

3.  Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy.

Authors:  Aaron J Polichnowski; Hector Licea-Vargas; Maria Picken; Jianrui Long; Rashmi Bisla; Geoffrey A Williamson; Anil K Bidani; Karen A Griffin
Journal:  Am J Physiol Renal Physiol       Date:  2015-06-24

4.  Apigenin attenuates diabetes-associated cognitive decline in rats via suppressing oxidative stress and nitric oxide synthase pathway.

Authors:  Xiao-Yuan Mao; Jing Yu; Zhao-Qian Liu; Hong-Hao Zhou
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  Blood glucose fluctuation accelerates renal injury involved to inhibit the AKT signaling pathway in diabetic rats.

Authors:  Changjiang Ying; Xiaoyan Zhou; Zhenzhen Chang; Hongwei Ling; Xingbo Cheng; Wei Li
Journal:  Endocrine       Date:  2016-02-09       Impact factor: 3.633

6.  Insulin regulates nitric oxide production in the kidney collecting duct cells.

Authors:  Gaurav Pandey; Ekta Makhija; Nelson George; Bandana Chakravarti; Madan M Godbole; Carolyn M Ecelbarger; Swasti Tiwari
Journal:  J Biol Chem       Date:  2014-12-22       Impact factor: 5.157

7.  Resistance to renal damage by chronic nitric oxide synthase inhibition in the Wistar-Furth rat.

Authors:  Aaron Erdely; Gary Freshour; Chris Baylis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-01       Impact factor: 3.619

8.  Simvastatin reverses podocyte injury but not mesangial expansion in early stage type 2 diabetes mellitus.

Authors:  P Wei; P R Grimm; D C Settles; C R Balwanz; B J Padanilam; S C Sansom
Journal:  Ren Fail       Date:  2009       Impact factor: 2.606

9.  Over-production of nitric oxide by oxidative stress-induced activation of the TGF-β1/PI3K/Akt pathway in mesangial cells cultured in high glucose.

Authors:  Yun-peng Zhai; Qian Lu; Yao-wu Liu; Qian Cheng; Ya-qin Wei; Fan Zhang; Cheng-lin Li; Xiao-xing Yin
Journal:  Acta Pharmacol Sin       Date:  2013-03-25       Impact factor: 6.150

10.  Association of genetic variants of NOS1AP with type 2 diabetes in a Chinese population.

Authors:  C Hu; C Wang; R Zhang; M C Ng; Y Bao; C Wang; W Y So; R C Ma; X Ma; J C Chan; K Xiang; W Jia
Journal:  Diabetologia       Date:  2009-11-24       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.